Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s11060-024-04881-2.

Title:
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions | Journal of Neuro-Oncology
Description:
Glioblastoma (GBM), the most common and aggressive primary central nervous system (CNS) tumor in adults, continues to have a dismal prognosis. Across hundreds of clinical trials, few novel approaches have translated to clinical practice while survival has improved by only a few months over the past three decades. Randomized controlled trials of immune checkpoint inhibitors (ICIs), which have seen impressive success for advanced or metastatic extracranial solid tumors, have so far failed to demonstrate a clinical benefit for patients with GBM. This has been secondary to GBM heterogeneity, the unique immunosuppressive CNS microenvironment, immune-evasive strategies by cancer cells, and the rapid evolution of tumor on therapy. This review aims to summarize findings from major clinical trials of ICIs for GBM, review historic failures, and describe currently promising avenues of investigation. We explore the biological mechanisms driving ICI responses, focusing on the role of the tumor microenvironment, immune evasion, and molecular biomarkers. Beyond conventional monotherapy approaches targeting PD-1, PD-L1, CTLA-4, we describe emerging approaches for GBM, such as dual-agent ICIs, and combination of ICIs with oncolytic virotherapy, antigenic peptide vaccines, chimeric antigenic receptor (CAR) T-cell therapy, along with nanoparticle-based delivery systems to enhance ICI efficacy. We highlight potential strategies for improving patient selection and treatment personalization, along with real-time, longitudinal monitoring of therapeutic responses through advanced imaging and liquid biopsy techniques. Integrated radiomics, tissue, and plasma-based analyses, may potentially uncover immunotherapeutic response signatures, enabling early, adaptive therapeutic adjustments. By specifically targeting current therapeutic challenges, outcomes for GBM patients may potentially be improved.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, pubmed, google, scholar, glioblastoma, cas, cancer, central, immune, neurooncology, immunotherapy, httpsdoiorgs, clinical, tumor, trial, phase, oncol, checkpoint, usa, patients, response, brain, wang, nature, survival, cell, ahluwalia, nat, chen, zhang, recurrent, medicine, research, mansouri, therapy, med, lim, clin, liu, university, inhibitors, gbm, cns, tumors, dna, newly, diagnosed, pembrolizumab, lee, gliomas,

Topics {✒️}

replication-repair-deficient month download article/chapter blood-brain barrier disruption ipilimumab versus ipilimumab comprehensive imaging-based review igf-1r antisense oligonucleotide pi3k-akt-mtor pathway high-risk resectable melanoma low-intensity focused ultrasound central nervous system circulating tumour dna cbm complex/nf-κb mapk/p27 signaling pathways targeting mapk pathway immune-related prognostic signature late-stage human malignancies icgc mmml-seq consortium minimally-invasive diagnostics surveillance nanoparticle-based delivery systems tumor-treating fields therapy plasma cell-free dna cns tumors—prognostic markers immune-related response criteria full article pdf anti-pd-1 immunotherapy clinical trial support lópez-diaz de cerio radiomics-based machine learning focused ultrasound foundation jama network open peritumoral brain parenchyma phase iii trial blood based assay article badani privacy choices/manage cookies checkpoint inhibitor failure anti-pd-1 blockade tumor-derived dna bevacizumab versus pembrolizumab scientific advisory boardmemberships clinical cancer research circulating tumor dna randomized phase ii chimeric antigen receptor immune checkpoint inhibitors plasma-based analyses van den bent cytotoxic t-lymphocyte autologous cell immunotherapy displays therapeutic synergy

Questions {❓}

  • Chen E, Ling AL, Reardon DA, Chiocca EA (2024) Lessons learned from phase 3 trials of immunotherapy for glioblastoma: time for longitudinal sampling?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions
         description:Glioblastoma (GBM), the most common and aggressive primary central nervous system (CNS) tumor in adults, continues to have a dismal prognosis. Across hundreds of clinical trials, few novel approaches have translated to clinical practice while survival has improved by only a few months over the past three decades. Randomized controlled trials of immune checkpoint inhibitors (ICIs), which have seen impressive success for advanced or metastatic extracranial solid tumors, have so far failed to demonstrate a clinical benefit for patients with GBM. This has been secondary to GBM heterogeneity, the unique immunosuppressive CNS microenvironment, immune-evasive strategies by cancer cells, and the rapid evolution of tumor on therapy. This review aims to summarize findings from major clinical trials of ICIs for GBM, review historic failures, and describe currently promising avenues of investigation. We explore the biological mechanisms driving ICI responses, focusing on the role of the tumor microenvironment, immune evasion, and molecular biomarkers. Beyond conventional monotherapy approaches targeting PD-1, PD-L1, CTLA-4, we describe emerging approaches for GBM, such as dual-agent ICIs, and combination of ICIs with oncolytic virotherapy, antigenic peptide vaccines, chimeric antigenic receptor (CAR) T-cell therapy, along with nanoparticle-based delivery systems to enhance ICI efficacy. We highlight potential strategies for improving patient selection and treatment personalization, along with real-time, longitudinal monitoring of therapeutic responses through advanced imaging and liquid biopsy techniques. Integrated radiomics, tissue, and plasma-based analyses, may potentially uncover immunotherapeutic response signatures, enabling early, adaptive therapeutic adjustments. By specifically targeting current therapeutic challenges, outcomes for GBM patients may potentially be improved.
         datePublished:2024-11-21T00:00:00Z
         dateModified:2024-11-21T00:00:00Z
         pageStart:531
         pageEnd:547
         sameAs:https://doi.org/10.1007/s11060-024-04881-2
         keywords:
            Immunotherapy
            Brain malignancy
            Immune exhaustion
            Pembrolizumab
            Ipilimumab
            Nivolumab
            Durvalumab
            Oncology
            Neurology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-024-04881-2/MediaObjects/11060_2024_4881_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-024-04881-2/MediaObjects/11060_2024_4881_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-024-04881-2/MediaObjects/11060_2024_4881_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-024-04881-2/MediaObjects/11060_2024_4881_Fig4_HTML.png
         isPartOf:
            name:Journal of Neuro-Oncology
            issn:
               1573-7373
               0167-594X
            volumeNumber:171
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Aarav Badani
               affiliation:
                     name:Penn State Health Milton S. Hershey Medical Center
                     address:
                        name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
                        type:PostalAddress
                     type:Organization
                     name:University of California
                     address:
                        name:Department of Neuroscience, University of California, Berkeley, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ahmad Ozair
               affiliation:
                     name:University of Maryland School of Medicine
                     address:
                        name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mustafa Khasraw
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Graeme F. Woodworth
               affiliation:
                     name:University of Maryland School of Medicine
                     address:
                        name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
                     address:
                        name:Brain Tumor Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND)
                     address:
                        name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND), Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pallavi Tiwari
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Radiology and Biomedical Engineering, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
                     name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare
                     address:
                        name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Manmeet S. Ahluwalia
               affiliation:
                     name:Baptist Health South Florida
                     address:
                        name:Miami Cancer Institute, Baptist Health South Florida, Miami, USA
                        type:PostalAddress
                     type:Organization
                     name:Herbert Wertheim College of Medicine, Florida International University
                     address:
                        name:Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alireza Mansouri
               affiliation:
                     name:Penn State Health Milton S. Hershey Medical Center
                     address:
                        name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
                        type:PostalAddress
                     type:Organization
                     name:Penn State Health Milton S. Hershey Medical Center
                     address:
                        name:Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions
      description:Glioblastoma (GBM), the most common and aggressive primary central nervous system (CNS) tumor in adults, continues to have a dismal prognosis. Across hundreds of clinical trials, few novel approaches have translated to clinical practice while survival has improved by only a few months over the past three decades. Randomized controlled trials of immune checkpoint inhibitors (ICIs), which have seen impressive success for advanced or metastatic extracranial solid tumors, have so far failed to demonstrate a clinical benefit for patients with GBM. This has been secondary to GBM heterogeneity, the unique immunosuppressive CNS microenvironment, immune-evasive strategies by cancer cells, and the rapid evolution of tumor on therapy. This review aims to summarize findings from major clinical trials of ICIs for GBM, review historic failures, and describe currently promising avenues of investigation. We explore the biological mechanisms driving ICI responses, focusing on the role of the tumor microenvironment, immune evasion, and molecular biomarkers. Beyond conventional monotherapy approaches targeting PD-1, PD-L1, CTLA-4, we describe emerging approaches for GBM, such as dual-agent ICIs, and combination of ICIs with oncolytic virotherapy, antigenic peptide vaccines, chimeric antigenic receptor (CAR) T-cell therapy, along with nanoparticle-based delivery systems to enhance ICI efficacy. We highlight potential strategies for improving patient selection and treatment personalization, along with real-time, longitudinal monitoring of therapeutic responses through advanced imaging and liquid biopsy techniques. Integrated radiomics, tissue, and plasma-based analyses, may potentially uncover immunotherapeutic response signatures, enabling early, adaptive therapeutic adjustments. By specifically targeting current therapeutic challenges, outcomes for GBM patients may potentially be improved.
      datePublished:2024-11-21T00:00:00Z
      dateModified:2024-11-21T00:00:00Z
      pageStart:531
      pageEnd:547
      sameAs:https://doi.org/10.1007/s11060-024-04881-2
      keywords:
         Immunotherapy
         Brain malignancy
         Immune exhaustion
         Pembrolizumab
         Ipilimumab
         Nivolumab
         Durvalumab
         Oncology
         Neurology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-024-04881-2/MediaObjects/11060_2024_4881_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-024-04881-2/MediaObjects/11060_2024_4881_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-024-04881-2/MediaObjects/11060_2024_4881_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-024-04881-2/MediaObjects/11060_2024_4881_Fig4_HTML.png
      isPartOf:
         name:Journal of Neuro-Oncology
         issn:
            1573-7373
            0167-594X
         volumeNumber:171
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Aarav Badani
            affiliation:
                  name:Penn State Health Milton S. Hershey Medical Center
                  address:
                     name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
                     type:PostalAddress
                  type:Organization
                  name:University of California
                  address:
                     name:Department of Neuroscience, University of California, Berkeley, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ahmad Ozair
            affiliation:
                  name:University of Maryland School of Medicine
                  address:
                     name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mustafa Khasraw
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Graeme F. Woodworth
            affiliation:
                  name:University of Maryland School of Medicine
                  address:
                     name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
                  address:
                     name:Brain Tumor Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND)
                  address:
                     name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND), Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pallavi Tiwari
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Radiology and Biomedical Engineering, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
                  name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare
                  address:
                     name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Manmeet S. Ahluwalia
            affiliation:
                  name:Baptist Health South Florida
                  address:
                     name:Miami Cancer Institute, Baptist Health South Florida, Miami, USA
                     type:PostalAddress
                  type:Organization
                  name:Herbert Wertheim College of Medicine, Florida International University
                  address:
                     name:Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alireza Mansouri
            affiliation:
                  name:Penn State Health Milton S. Hershey Medical Center
                  address:
                     name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
                     type:PostalAddress
                  type:Organization
                  name:Penn State Health Milton S. Hershey Medical Center
                  address:
                     name:Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neuro-Oncology
      issn:
         1573-7373
         0167-594X
      volumeNumber:171
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Penn State Health Milton S. Hershey Medical Center
      address:
         name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Neuroscience, University of California, Berkeley, USA
         type:PostalAddress
      name:University of Maryland School of Medicine
      address:
         name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, USA
         type:PostalAddress
      name:University of Maryland School of Medicine
      address:
         name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
         type:PostalAddress
      name:University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
      address:
         name:Brain Tumor Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, USA
         type:PostalAddress
      name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND)
      address:
         name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND), Baltimore, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Radiology and Biomedical Engineering, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare
      address:
         name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare, Madison, USA
         type:PostalAddress
      name:Baptist Health South Florida
      address:
         name:Miami Cancer Institute, Baptist Health South Florida, Miami, USA
         type:PostalAddress
      name:Herbert Wertheim College of Medicine, Florida International University
      address:
         name:Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, USA
         type:PostalAddress
      name:Penn State Health Milton S. Hershey Medical Center
      address:
         name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
         type:PostalAddress
      name:Penn State Health Milton S. Hershey Medical Center
      address:
         name:Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Aarav Badani
      affiliation:
            name:Penn State Health Milton S. Hershey Medical Center
            address:
               name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
               type:PostalAddress
            type:Organization
            name:University of California
            address:
               name:Department of Neuroscience, University of California, Berkeley, USA
               type:PostalAddress
            type:Organization
      name:Ahmad Ozair
      affiliation:
            name:University of Maryland School of Medicine
            address:
               name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
               type:PostalAddress
            type:Organization
      name:Mustafa Khasraw
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, USA
               type:PostalAddress
            type:Organization
      name:Graeme F. Woodworth
      affiliation:
            name:University of Maryland School of Medicine
            address:
               name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
               type:PostalAddress
            type:Organization
            name:University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
            address:
               name:Brain Tumor Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, USA
               type:PostalAddress
            type:Organization
            name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND)
            address:
               name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND), Baltimore, USA
               type:PostalAddress
            type:Organization
      name:Pallavi Tiwari
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Radiology and Biomedical Engineering, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
            name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare
            address:
               name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare, Madison, USA
               type:PostalAddress
            type:Organization
      name:Manmeet S. Ahluwalia
      affiliation:
            name:Baptist Health South Florida
            address:
               name:Miami Cancer Institute, Baptist Health South Florida, Miami, USA
               type:PostalAddress
            type:Organization
            name:Herbert Wertheim College of Medicine, Florida International University
            address:
               name:Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, USA
               type:PostalAddress
            type:Organization
      name:Alireza Mansouri
      affiliation:
            name:Penn State Health Milton S. Hershey Medical Center
            address:
               name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
               type:PostalAddress
            type:Organization
            name:Penn State Health Milton S. Hershey Medical Center
            address:
               name:Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
      name:Department of Neuroscience, University of California, Berkeley, USA
      name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
      name:Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, USA
      name:Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA
      name:Brain Tumor Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, USA
      name:University of Maryland – Medicine Institute for Neuroscience Discovery (UM-MIND), Baltimore, USA
      name:Department of Radiology and Biomedical Engineering, University of Wisconsin, Madison, USA
      name:William S. Middleton Memorial Veterans Affairs (VA) Healthcare, Madison, USA
      name:Miami Cancer Institute, Baptist Health South Florida, Miami, USA
      name:Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, USA
      name:Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
      name:Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center, Hershey, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(358)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Foundation
  • Prism.js

CDN Services {📦}

  • Crossref

4.39s.